Document is current
Any future updates will be listed below
-
Authors
Dedinszki, Dóra
Szeri, Flóra
Kozák, Eszter
Pomozi, Viola
Tőkési, Natália
Mezei, Tamás Róbert
Merczel, Kinga
Letavernier, Emmanuel
Tang, Ellie
Le Saux, Olivier
Arányi, Tamás
van de Wetering, Koen
Váradi, András https://orcid.org/0000-0002-2722-7120
-
Funding
Funding for this research was provided by:
PXE International
Ingeborg v.F. McKee Fund (15ADVC‐74403)
Hungarians Research Grants OTKA (104227)
Hungarians Research Grants OTKA (114336)
Hungarian Innovation Grants VKSz (VKSz14‐1‐2015‐0155)
HHS|NIH|National Heart, Lung, and Blood Institute (HL108249)
HHS|NIH|National Institute of General Medical Sciences (GM103341)
- License Information
-
More Information
Article History
Received: 3 January 2017
Revised: 9 June 2017
Accepted: 21 June 2017
First Online: 12 July 2017
Conflict of interest
: D.D., F.Sz., K.vdW., and A.V. filed a patent “Oral pyrophosphate for use in reducing tissue calcification” to the Netherland Patent Office (P32885NL00/RKI).
